Recent research sheds light on how changes in the chemical structure of a protein called Interleukin-6 affect lung cancer’s growth and response to treatment. Scientists from National Cheng Kung ...

Summary: Tocilizumab is a novel monoclonal antibody that competitively inhibits the binding of interleukin-6 (IL-6) to its receptor (IL-6R). Inhibiting the entire receptor complex prevents IL-6 ...

Clinical diagnosis is difficult and no reliable diagnostic test exists. Interleukin-6 (IL-6) is a central mediator of the sepsis syndrome. In this study we examined the diagnostic value of plasma ...

Get Instant Summarized Text (Gist) Interleukin-6 (IL-6) has been identified as a promising biomarker for early sepsis detection in neonates, children, and pregnant women. IL-6 outperformed ...

The study’s findings showed that those who have higher levels of the inflammatory markers interleukin-6 and C-reactive protein are also more likely to have low emotional clarity. Mental ...